发明授权
US5039663A Antibiotics called "mureidomycins A, B, C, and D" and their therapeutic
use
失效
抗生素称为“mureidomycins A，B，C和D”及其治疗用途
- 专利标题： Antibiotics called "mureidomycins A, B, C, and D" and their therapeutic use
- 专利标题（中）： 抗生素称为“mureidomycins A，B，C和D”及其治疗用途
-
申请号： US253450申请日： 1988-10-04
-
公开(公告)号： US5039663A公开(公告)日： 1991-08-13
- 发明人: Tatsuo Haneishi , Masatoshi Inukai , Keiko Shimizu , Fujio Isono , Yoshiharu Sakaida , Takeshi Kinoshita
- 申请人： Tatsuo Haneishi , Masatoshi Inukai , Keiko Shimizu , Fujio Isono , Yoshiharu Sakaida , Takeshi Kinoshita
- 申请人地址： JPX Tokyo
- 专利权人： Sankyo Company Limited
- 当前专利权人： Sankyo Company Limited
- 当前专利权人地址： JPX Tokyo
- 优先权： JPX61-115639 19860520; JPX61-137567 19860613
- 主分类号： C12P1/06
- IPC分类号： C12P1/06
摘要：
Novel compounds, called mureidomycins A, B, C and D, may be prepared by cultivation of a suitable microorganism of the genus Streptomyces, especially Streptomyces flavidovirens SANK 60486 (FERM P-8636, FERM BP-1347). These represent a wholly new class of antibiotics, which are valuable in the treatment of infections caused by a variety of bacteria, notably of the genus Pseudomonas.
公开/授权文献
信息查询
